Canyon Capital Advisors LLC Bausch Health Companies Inc. Transaction History

Canyon Capital Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $18.4 Million - $61.4 Million	-2,600,353 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $8.68 Million - $11.2 Million	-401,900 Reduced 13.39%	2,600,353 $59.4 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $1.06 Million - $1.34 Million	46,253 Added 1.56%	3,002,253 $82.9 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $12.6 Million - $15.2 Million	505,000 Added 20.6%	2,956,000 $82.3 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $7.84 Million - $9.35 Million	286,000 Added 13.21%	2,451,000 $71.9 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $34.6 Million - $55.7 Million	-1,618,872 Reduced 42.78%	2,165,000 $68.7 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $11.9 Million - $16.4 Million	778,716 Added 25.91%	3,783,872 $78.7 Million
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $44.7 Million - $60.5 Million	3,005,156 New	3,005,156 $46.7 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Canyon Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Canyon Capital Advisors LLC with notifications on news.